FluroTech Ltd.の収入 は-9.16CAD$です。
普通株主に帰属する当期純利益は、純利益から優先配当金を差し引いた金額です。優先配当
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
FluroTech Ltd., a technology and marketing company, focuses on the commercialization of various technologies in the pandemic defense sector. It provides a pandemic defense platform, a saliva-based antigen test that targets active infections evidenced by the presence of live viral particles. The company is headquartered in Calgary, Canada.